Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-25 @ 2:54 AM
NCT ID:
NCT00900133
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed primary adenocarcinoma of the breast
* Stage I-III disease
* No evidence of metastatic disease
* Newly diagnosed disease
* Hormone receptor status:
* Estrogen receptor-positive- or -negative tumor
PATIENT CHARACTERISTICS:
Sex
* Not specified
Menopausal status
* Not specified
Performance status
* Not specified
Life expectancy
* Not specified
Hematopoietic
* Not specified
Hepatic
* Not specified
Renal
* Not specified
Other
* Not pregnant
* No Crohn's disease
* No arthritis
* No psoriasis
* No lupus erythematosus
* No multiple sclerosis
* No other severe active inflammation
* Not C-reactive protein positive
* No HIV positivity
* No other serious medical or psychiatric illness
PRIOR CONCURRENT THERAPY:
Radiotherapy
* No prior radiotherapy for breast cancer
Surgery
* No prior organ transplantation
Other
* No prior systemic therapy for breast cancer
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00900133
Study Brief:
Protocol Section:
NCT00900133